Reproduction · 1967 · 11 citations · 3 references
MedicineGynecologyPharmacologyContraceptionReproductive EndocrinologyReproductive MedicineHormonal ContraceptionHormonal TherapyReproductive PharmacologyEndometrial SuppressionEstrogen PharmacologyEstrogen-progestin ContraceptionHormonal Contraceptive Therapy
Summary. An assay to determine the anti-oestrogenic potency of progestagens in women is described. The progressive increase in endometrial glandular suppression with increasing doses of progestagens is the basis of the assay. Norethindrone (oestrogen free) is three times as potent as chlormadinone acetate with a 95% confidence limit of 2·3 to 4·0. This is in contrast to the greater secretory potency of chlormadinone acetate. It is suggested that the anti-oestrogenic action of progestagens is of some importance in the selection of compounds for contraceptives of the combined progestagen—oestrogen, and of great importance for those of the continuous low dose progestagen types. This property may also be desirable in the treatment of both endometrial hyperplasia and adenocarcinoma.
3
Low Doses of Progestogen as an Approach to Fertility Control
Jorge Martínez-Manautou, Vincente Cortez, Juan Manuel Llopis Giner et al. · Fertility and Sterility · 1966 · 117 citations
Medicine, Endocrinology, Gynecology +14